Opportunities and challenges for targeted radionuclide therapy of prostate cancer using 161Tb
Langue
EN
Article de revue
Ce document a été publié dans
Médecine Nucléaire. 2023-10-05, vol. 47, n° 6, p. 333-338
Résumé en anglais
161Tb has aroused great interest to improve response rate of targeted radionuclide therapy due to its unique decay features. In this review article, decay properties of medically relevant radionuclides of the terbium element ...Lire la suite >
161Tb has aroused great interest to improve response rate of targeted radionuclide therapy due to its unique decay features. In this review article, decay properties of medically relevant radionuclides of the terbium element are first described. Next, modeling studies, production, preclinical and clinical studies performed using 161Tb in prostate cancer are reviewed.< Réduire
Mots clés en anglais
Prostate cancer
Therapy
Project ANR
Initiative d'excellence de l'Université de Bordeaux - ANR-10-IDEX-0003